drug
as of 2026-07-01Sublingual film containing BXCL501 (Dexmedetomidine)
at a glance
small molecule
Pre-approval / investigational in the US
Developed by BioXcel Therapeutics Inc
1 trials in the graph
Synthesized from structured facts only — each point cited above.
Mechanism & identity
Modality
small molecule
Indications
Investigational (via trials)
Trials
1
Sub-Lingual Dexmedetomidine in Agitation Associated With Schizophrenia
NCT04010305Phase 1Completed
Facts & assertions
0 sourced
No assertions recorded for this entity.
relationships
The graph out of here
developer
company
indication